Aquestive Therapeutics Files Prospectus For Offering 230,271 Common Shares On Behalf Of Selling Shareholders

Benzinga Newsdesk www.benzinga.com Neutral 92.8%

Neg 0% Neu 92.8% Pos 0%

https://www.sec.gov/Archives/edgar/data/1398733/000114036126026568/ny20076831x1_s3.htm

Comments

No comments yet. Be the first!